1832 ASSET MANAGEMENT L.P. – Neurocrine Biosciences, Inc. Transaction History
1832 ASSET MANAGEMENT L.P. portfolio value:
$50.43M
portfolio value
1832 ASSET MANAGEMENT L.P. quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +513.57% | 397.5K shares | 42.89M | $106.21 | 474.9K |
| Q2 2022 | share | Increase | 0.00% | 77.4K shares | 7.54M | $97.48 | 77.4K |
| Q3 2020 | share | Decrease | -100.00% | -205.6K shares | -25.54M | $96.16 | 0 |
| Q2 2020 | share | Decrease | -63.04% | -350.7K shares | -24.38M | $122 | 205.6K |
| Q1 2020 | share | Decrease | -12.79% | -81.6K shares | -17.35M | $86.55 | 556.3K |
| Q4 2019 | share | Increase | +20.34% | 107.8K shares | 20.52M | $107.49 | 637.9K |
| Q3 2019 | share | Increase | 0.00% | 530.1K shares | 46.75M | $90.11 | 530.1K |
| Q4 2018 | share | Decrease | -100.00% | -658.7K shares | -79.24M | $71.41 | 0 |
| Q3 2018 | share | Increase | +70.03% | 271.3K shares | 42.21M | $122.95 | 658.7K |
| Q2 2018 | share | Increase | 0.00% | 387.4K shares | 37.03M | $98.24 | 387.4K |
| Q1 2018 | share | Decrease | -100.00% | -63.7K shares | -4.92M | $82.93 | 0 |
| Q4 2017 | share | Increase | 0.00% | 63.7K shares | 4.92M | $77.59 | 63.7K |